Cytek Biosciences Inc
CTKB3.840USD
+0.200+5.49%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
3.840USD+3.840After-hours (ET)
489.98MMarket Cap
LossP/E TTM
Cytek Biosciences Inc
3.840
+0.200+5.49%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Total revenue
-7.59%41.46M
-1.30%57.48M
7.29%51.50M
-6.19%46.62M
20.96%44.86M
20.48%58.23M
18.59%48.00M
23.74%49.69M
5.77%37.09M
24.28%48.34M
17.75%40.48M
32.07%40.16M
44.46%35.06M
27.03%38.89M
36.98%34.38M
58.90%30.41M
34.93%24.27M
--30.62M
--25.10M
--19.14M
--17.99M
Revenue
-7.59%41.46M
-1.30%57.48M
7.29%51.50M
-6.19%46.62M
20.96%44.86M
20.48%58.23M
18.59%48.00M
23.74%49.69M
5.77%37.09M
24.28%48.34M
17.75%40.48M
32.07%40.16M
44.46%35.06M
27.03%38.89M
36.98%34.38M
58.90%30.41M
34.93%24.27M
--30.62M
--25.10M
--19.14M
--17.99M
Cost of revenue
-2.50%21.30M
-5.40%23.82M
8.03%22.50M
-1.63%21.18M
36.12%21.85M
32.82%25.18M
52.93%20.82M
38.04%21.53M
7.81%16.05M
24.28%18.96M
3.94%13.62M
46.28%15.60M
52.13%14.89M
36.60%15.26M
38.18%13.10M
-1.87%10.66M
1.80%9.79M
--11.17M
--9.48M
--10.87M
--9.61M
Operating expenses
1.51%56.43M
-6.65%54.49M
2.44%55.75M
-6.25%55.14M
12.88%55.59M
20.97%58.37M
39.12%54.42M
43.29%58.82M
31.61%49.25M
28.41%48.25M
24.26%39.12M
54.34%41.05M
61.72%37.42M
65.22%37.58M
71.22%31.48M
37.42%26.60M
23.76%23.14M
--22.74M
--18.39M
--19.35M
--18.70M
R&D expenses
-0.72%9.72M
-10.54%9.72M
-11.54%9.88M
-17.59%10.00M
-1.78%9.80M
11.51%10.87M
29.14%11.17M
43.86%12.14M
24.29%9.97M
37.75%9.75M
42.32%8.65M
36.20%8.44M
57.54%8.03M
61.37%7.08M
80.04%6.08M
112.41%6.19M
68.90%5.09M
--4.38M
--3.38M
--2.92M
--3.02M
Depreciation, depletion, and amortization
17.19%2.88M
9.90%2.74M
8.37%2.81M
1.43%2.48M
36.65%2.46M
30.78%2.49M
94.74%2.59M
57.23%2.44M
22.52%1.80M
178.39%1.91M
586.08%1.33M
673.63%1.56M
780.24%1.47M
--685.00K
--194.00K
--201.00K
59.05%167.00K
----
----
----
--105.00K
Operating profit
-39.51%-14.97M
2279.56%2.99M
33.83%-4.25M
6.57%-8.53M
11.74%-10.73M
-263.10%-137.00K
-572.06%-6.42M
-924.35%-9.13M
-415.99%-12.16M
-93.62%84.00K
-53.05%1.36M
-123.38%-891.00K
-308.22%-2.36M
-83.28%1.32M
-56.83%2.90M
1848.17%3.81M
259.44%1.13M
--7.88M
--6.71M
---218.00K
---710.00K
Net non-operating interest income (expenses)
Non-operating interest income
-62.62%508.00K
372.79%6.85M
-11.65%1.43M
17.90%1.42M
-36.58%1.36M
-44.86%1.45M
2.40%1.62M
207.16%1.20M
11805.56%2.14M
14488.89%2.63M
13100.00%1.58M
4244.44%391.00K
80.00%18.00K
260.00%18.00K
300.00%12.00K
-43.75%9.00K
-88.37%10.00K
--5.00K
--3.00K
--16.00K
--86.00K
Non-operating interest expense
-34.01%291.00K
----
-80.00%119.00K
-67.24%134.00K
-34.47%441.00K
-42.65%394.00K
-8.32%595.00K
-36.79%409.00K
14.07%673.00K
39.63%687.00K
47.17%649.00K
49.42%647.00K
57.33%590.00K
49.09%492.00K
21950.00%441.00K
43200.00%433.00K
--375.00K
--330.00K
--2.00K
--1.00K
--0.00
Special income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
Other non-operating income (expenses)
324.30%3.49M
-84.63%491.00K
155.88%3.09M
-96.61%59.00K
-50.18%823.00K
52.75%3.19M
371.46%1.21M
785.04%1.74M
541.71%1.65M
624.06%2.09M
-13.23%-445.00K
-111.67%-254.00K
39.19%-374.00K
-188.47%-399.00K
-312.43%-393.00K
-130.38%-120.00K
-1562.16%-615.00K
--451.00K
--185.00K
--395.00K
---37.00K
Income before tax
-25.28%-11.27M
151.11%10.32M
103.75%157.00K
-8.96%-7.19M
0.52%-8.99M
-0.07%4.11M
-326.22%-4.18M
-370.74%-6.59M
-173.69%-9.04M
826.58%4.11M
-10.84%1.85M
-142.88%-1.40M
-2273.03%-3.30M
-94.45%444.00K
-69.91%2.08M
1601.56%3.27M
123.00%152.00K
--8.00M
--6.90M
--192.00K
---661.00K
Income tax
104.82%136.00K
148.85%680.00K
-134.52%-784.00K
247.17%3.25M
-26.47%-2.82M
-451.52%-1.39M
913.84%2.27M
-215.74%-2.21M
-95.02%-2.23M
-75.39%396.00K
-65.80%224.00K
-217.09%-699.00K
-2390.00%-1.15M
-33.04%1.61M
83.47%655.00K
107.54%597.00K
-71.91%50.00K
--2.40M
--357.00K
---7.92M
--178.00K
Income after tax
-84.83%-11.40M
75.23%9.64M
114.58%941.00K
-137.78%-10.43M
9.37%-6.17M
48.01%5.50M
-497.05%-6.46M
-525.07%-4.39M
-215.43%-6.81M
419.14%3.72M
14.51%1.63M
-126.29%-702.00K
-2215.69%-2.16M
-120.81%-1.17M
-78.29%1.42M
-67.08%2.67M
112.16%102.00K
--5.60M
--6.54M
--8.11M
---839.00K
Net income from continuous operations
-84.83%-11.40M
75.23%9.64M
114.58%941.00K
-137.78%-10.43M
9.37%-6.17M
48.01%5.50M
-497.05%-6.46M
-525.07%-4.39M
-215.43%-6.81M
419.14%3.72M
14.51%1.63M
-126.29%-702.00K
-2215.69%-2.16M
-120.81%-1.17M
-78.29%1.42M
-67.08%2.67M
112.16%102.00K
--5.60M
--6.54M
--8.11M
---839.00K
Net Income attributable to non-controlling interests
----
--0.00
----
----
----
-100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
626.92%189.00K
---40.00K
---104.00K
---137.00K
--26.00K
----
----
----
----
----
----
----
Net income attributable to controlling interests
-84.83%-11.40M
75.23%9.64M
114.58%941.00K
-137.78%-10.43M
9.37%-6.17M
55.94%5.50M
-487.52%-6.46M
-633.78%-4.39M
-236.81%-6.81M
--3.53M
381.50%1.67M
---598.00K
---2.02M
-100.00%0.00
-94.71%346.00K
-100.00%0.00
100.00%0.00
--5.60M
--6.54M
--8.11M
---839.00K
Net income attributable to common shareholders
-84.83%-11.40M
75.23%9.64M
114.58%941.00K
-137.78%-10.43M
9.37%-6.17M
55.94%5.50M
-487.52%-6.46M
-633.78%-4.39M
-236.81%-6.81M
--3.53M
381.50%1.67M
---598.00K
---2.02M
-100.00%0.00
-94.71%346.00K
-100.00%0.00
100.00%0.00
--5.60M
--6.54M
--8.11M
---839.00K
Basic earnings per share
-88.54%-0.09
81.27%0.07
115.14%0.01
-145.91%-0.08
6.21%-0.05
57.65%0.04
-483.27%-0.05
-625.39%-0.03
-232.94%-0.05
--0.03
287.77%0.01
--0.00
---0.02
--0.00
--0.00
--0.00
100.00%0.00
----
----
----
---0.01
Diluted earnings per share
-88.54%-0.09
81.27%0.07
114.95%0.01
-145.91%-0.08
6.21%-0.05
76.56%0.04
-494.75%-0.05
-625.39%-0.03
-232.94%-0.05
--0.02
295.07%0.01
--0.00
---0.02
--0.00
--0.00
--0.00
100.00%0.00
----
----
----
---0.01
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
